XML 31 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
12. Income taxes
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Income taxes - Note 12

12. INCOME TAXES

A provision for income taxes has not been recorded for 2016, 2015 and 2014, due to the valuation allowances placed against the net operating losses and deferred tax assets arising during such periods. A valuation allowance has been recorded for all deferred tax assets. Based on our history of losses since inception, the available objective evidence creates sufficient uncertainty regarding the realizability of the deferred tax assets.

At December 31, 2016, we have net operating loss carryforwards of approximately $371.6 million for federal income tax reporting purposes. In addition, we have research and development tax credits of $7.0 million. The net operating loss carryforwards and research and development credits available to offset future taxable income, if any, will expire in varying amounts from 2018 to 2036, if not previously used.

In addition to the tax benefits above, we have $310,000 of capital loss carryforwards that are scheduled to expire in 2017. In certain circumstances, as specified in the Internal Revenue Code, a 50% or more ownership change by certain combinations of our shareholders during any three year period would result in limitations on our ability to use a portion of our net operating loss carryforwards.

Deferred tax assets are summarized as follows (in thousands):

      December 31,
      2016     2015
Deferred tax assets, current            
     Reserves   $ 2,351    $ 2,581 
     Other     910      749 
Total gross deferred tax assets, current     3,261      3,330 
             
Deferred tax assets, non-current            
     Net operating loss carryforwards     126,335      122,281 
     R&D credit carryforwards     6,998      6,747 
     Depreciation/amortization deferred     20,024      20,848 
     Deferred revenue     2,091     
     Other     8,135      7,954 
Total gross deferred tax assets, non-current     163,583      157,830 
             
Net deferred taxes before valuation allowance     166,844      161,160 
Less: Valuation allowance     (166,844)     (161,160)
Deferred tax assets   $   $

 

The valuation allowance, permanent items, and the research and development credit carryforwards account for substantially all of the difference between our effective income tax rate and the federal statutory tax rate of 34%.

Certain net operating losses arise from the deductibility for tax purposes of compensation under nonqualified stock options equal to the difference between the fair value of the stock on the date of exercise and the exercise price of the options. For financial reporting purposes, the tax effect of this deduction, when recognized, is accounted for as a credit to shareholders' equity.

We did not have any unrecognized tax benefits at December 31, 2016 or 2015.

We recognize interest accrued and penalties related to unrecognized tax benefits in tax expense. During the years ended December 31, 2016, 2015, and 2014, we did not recognized any interest or penalties.

We file income tax returns in the U.S. federal jurisdiction and various states. Due to our operating loss and credit carryforwards, the U.S. federal statute of limitations remains open for 1998 and onward.